Age Group (in Years) | |||||
40 - 64 (%) [N = 643] | 65 - 74 (%) [N = 147] | ³75 (%) [N = 103] | p value | ||
Race | |||||
Chinese | 468 (72.8) | 103 (70.1) | 81 (78.6) | 0.572 | |
Malay | 114 (17.7) | 29 (19.7) | 11 (10.7) | ||
Indian | 33 (5.1) | 8 (5.4) | 7 (6.8) | ||
Others | 28 (4.4) | 7 (4.8) | 4 (3.9) | ||
Co-morbidities | |||||
Diabetes MELLITUS | 60 (9.3) | 38 (25.9) | 27 (26.2) | <0.001 | |
Cardiovascular disease | 124 (19.3) | 76 (51.7) | 54 (52.4) | <0.001 | |
Other disease | 38 (5.9) | 16 (10.9) | 19 (18.5) | <0.001 | |
Pulmonary disease | 29 (4.5) | 4 (2.7) | 3 (2.9) | ||
Central nervous system disease | 4 (0.6) | 11 (7.5) | 14 (13.6) | ||
Renal disease | 4 (0.6) | 1 (0.7) | 1 (1.0) | ||
Liver disease | 4 (0.6) | 0 (0.0) | 2 (1.9) |
| |
Clinical characteristics | |||||
Complaint | |||||
Presence of lump | 555 (86.3) | 127 (87.0) | 94 (92.2) | 0.143 | |
Screening detected (U/S or MMG) | 60 (9.3) | 8 (5.5) | 5 (4.9) | ||
Others (Pain/nipple discharge) | 28 (4.4) | 11 (7.5) | 3 (2.9) | ||
Bilateral CANCER | 39 (6.1) | 15 (10.2) | 8 (7.8) | 0.176 | |
Palpable axillary LN | 82 (17.3) | 22 (19.8) | 19 (24.7) | 0.283 | |
Presence of metastasis | 42 (6.7) | 13 (9.7) | 21 (22.2) | <0.001 | |
Metastatic site | |||||
Bone | 16 (38.1) | 4 (30.8) | 8 (38.1) | 0.823 | |
Lung/pleural | 4 (9.5) | 3 (23.1) | 2 (9.5) | ||
Liver (single) | 2 (4.8) | 0 (0.0) | 1 (4.8) | ||
Distant LN/brain | 2 (4.8) | 2 (15.4) | 2 (9.5) | ||
Multiple sites | 18 (42.9) | 4 (30.8) | 8 (38.1) | ||